Updates on ISO 14155 and N=1 Therapeutics Discussed by TGA
Investigators need to modify trial protocols and safety reporting mechanisms in line with the latest ISO 14155 updates to ensure compliance for upcoming high-risk clinical trials.
The TGA introduced new e-learning modules specifically detailing the Good Clinical Practice (GCP) Inspection Program and the expectations for sponsors and investigators during inspections.
These educational resources aim to enhance the understanding of GCP compliance, which is critical for ensuring safety in clinical trials and maintaining regulatory standards.
Stakeholders are encouraged to utilize the provided e-learning modules to improve their inspection readiness and compliance with GCP standards in Australia.
Regulatory Intelligence Lead
Review in the next regulatory intelligence cycle.
Launch of the 'Getting started: TGA's Good Clinical Practice (GCP) Inspection Program' module; provides practical examples and context for compliance with GCP standards in Australia.
Sponsors and clinical trial teams can use this new official resource to improve inspection readiness for GCP audits. The guidance clarifies the TGA's approach to inspecting safety reporting and trial oversight, which is essential for compliance with clinical trial safety obligations.
Stakeholders are encouraged to utilize the provided e-learning modules to improve their inspection readiness and compliance with GCP standards in Australia.
The TGA's new interactive e-learning modules assist stakeholders, especially sponsors and clinical trial teams, in understanding their regulatory obligations and improving their readiness for GCP audits. The modules provide clarity on the inspection process and emphasize the importance of compliance with safety reporting and trial oversight requirements.
What changed: The TGA introduced new e-learning modules specifically detailing the Good Clinical Practice (GCP) Inspection Program and the expectations for sponsors and investigators during inspections.
Why it matters: These educational resources aim to enhance the understanding of GCP compliance, which is critical for ensuring safety in clinical trials and maintaining regulatory standards.
Practical implication: Stakeholders are encouraged to utilize the provided e-learning modules to improve their inspection readiness and compliance with GCP standards in Australia.
Published from the Firecrawl policy change extraction pipeline.
Investigators need to modify trial protocols and safety reporting mechanisms in line with the latest ISO 14155 updates to ensure compliance for upcoming high-risk clinical trials.
Safety lead to: (1) perform a UK-clinical-trial safety reporting gap assessment against MHRA’s effective guidance sections (MedDRA coding; AE/SAE; RSI governance; SUSARs; annual safety reporting; USMs; serious breaches; temporary suspension), (2) update controlled SOPs/WIs and training records to reflect “effective” status as of 28 Apr 2026, and (3) document deviations/gaps and open CAPA where needed for ongoing UK trials and new submissions.
Sponsors and MAHs must review and align safety data collection and reporting protocols with the newly adopted guidelines while preparing for implementation of PRAC recommendations stemming from this meeting.
Healthcare facilities must utilize the new checklist during inspections to conduct gap analyses and ensure compliance with reporting requirements associated with their vigilance systems.